Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Merkel

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Progress in Clinical and Biological Research|January 1, 1988
P-glycoprotein gene amplification or overexpression is not detected in clinical breast cancer specimensD E Merkel, S A Fuqua, S M Hill, et al.
Cancer Treatment Reports|December 1, 1986
Central nervous system toxicity with fludarabineD E Merkel, N L Griffin, K Kagan-Hallet, et al.
Surgery, Gynecology & Obstetrics|August 1, 1992
Achieving local control for inflammatory carcinoma of the breastS F Sener, J P Imperato, J D Khandekar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplificationD E Merkel, S A Fuqua, A K Tandon, et al.
Cancer|September 15, 1993
DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancerD E Merkel, D J Winchester, R A Goldschmidt, et al.
Cancer Research|June 1, 1986
Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomasK D Bauer, D E Merkel, J N Winter, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1990
The importance of DNA flow cytometry in node-negative breast cancerD J Winchester, R B Duda, C Z August, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trialK L Tedesco, A D Thor, D H Johnson, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Progress in Clinical and Biological Research|January 1, 1988
P-glycoprotein gene amplification or overexpression is not detected in clinical breast cancer specimensD E Merkel, S A Fuqua, S M Hill, et al.
Cancer Treatment Reports|December 1, 1986
Central nervous system toxicity with fludarabineD E Merkel, N L Griffin, K Kagan-Hallet, et al.
Surgery, Gynecology & Obstetrics|August 1, 1992
Achieving local control for inflammatory carcinoma of the breastS F Sener, J P Imperato, J D Khandekar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplificationD E Merkel, S A Fuqua, A K Tandon, et al.
Cancer|September 15, 1993
DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancerD E Merkel, D J Winchester, R A Goldschmidt, et al.
Cancer Research|June 1, 1986
Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomasK D Bauer, D E Merkel, J N Winter, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1990
The importance of DNA flow cytometry in node-negative breast cancerD J Winchester, R B Duda, C Z August, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trialK L Tedesco, A D Thor, D H Johnson, et al.
Pageof 2